产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 100mg | 95% | 现货 | |||
| 250mg | 95% | 现货 | |||
| 1g | 95% | 现货 | |||
| 5g | 95% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 100mg | 95% | 现货 | |||
| 250mg | 95% | 现货 | |||
| 1g | 95% | 现货 | |||
| 5g | 95% | 现货 |
CAS No. |
2212022-56-3 |
|---|---|
中文名称 |
(S)-1-(4-氟-1-甲基-1H-吲唑-5-基)-3-(2-(4-氯-3,5-二甲基苯基)-4-甲基-4,5,6,7-四氢-2H-吡唑并[4,3-c]吡啶-3-基)-1H-咪唑-2(3H)-酮 |
英文名称 |
(S)-1-(4-Fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1,3-dihydro-2H-imidazol-2-one |
别名 |
2H-Imidazol-2-one, 1-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-4,5,6,7-tetrahydro-4-methyl-2H-pyrazolo[4,3-c]pyridin-3-yl]-3-(4-fluoro-1-methyl-1H-indazol-5-yl)-1,3-dihydro-;(S)-1-(4-fluoro-2-methyl-2H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1H-imidazol-2(3H)-one;(S)-1-(4-Fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1H-imidazol-2(3H)-one;(S)-1-(4-Fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1,3-dihydro-2H-imidazol-2-one;(S)-1-(4-fluoro-1-methyl-1H-indazol-5-yl)}-3-(2-(4- fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H- pyrazolo[4,3-c]pyridine-3-yl)}-1,3-dihydro-2H-imidazol-2-one;Orforglipron Intermediate;5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylet;3-((1S,2R)-1-(5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3- (3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1Himidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7- tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl)-2- methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one |
标准英文名 |
(S)-1-(4-Fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1,3-dihydro-2H-imidazol-2-one |
分子式 |
C26H25F2N7O |
分子量 |
489.53 |
精确分子量 |
489.21 |
SMILES |
C[C@H]1C2=C(N(N=C2CCN1)C3=CC(C)=C(F)C(C)=C3)N4C(=O)N(C=C4)C=5C(F)=C6C(=CC5)N(C)N=C6 |
标准SMILES |
CN1N=CC2C1=CC=C(C=2F)N1C=CN(C1=O)C1=C2[C@H](C)NCCC2=NN1C1=CC(C)=C(F)C(C)=C1 |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
RUAXBTGNBAFEOY-INIZCTEOSA-N |
危险类别(旧) |
H302,H315,H319 |
存储要求 |
Sealed in dry,2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A ) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|